This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Wisconsin Alumni Research Foundation, Princeton University. Active years: 2019-2020.
Company Filing History:
3 out of 4,235 
2 out of 1,133 
Years Active: 2019-2020
Title: Yongna Xing: Innovator in Cancer Treatment
Introduction
Yongna Xing is a prominent inventor based in Middleton, WI (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, his work focuses on novel methods and compounds that target critical interactions in tumor biology.
Latest Patents
One of Yongna Xing's latest patents is titled "Use of peptides that block metadherin-SND1 interaction as treatment for cancer." This patent describes methods for treating cancer by disrupting the interaction between metadherin and Staphylococcal nuclease domain-containing 1 (SND1). By using peptides or other compounds that inhibit this binding, the activity of the MTDH-SND1 complex in tumor cells can be effectively reduced. Another significant patent is "Aryl hydrocarbon receptor ligands from kynurenine," which relates to novel compounds that act as aryl hydrocarbon receptor (AHR) ligands. This invention also includes methods for activating the AHR receptor in a subject, showcasing the potential therapeutic applications of these compounds.
Career Highlights
Yongna Xing has worked with esteemed institutions such as the Wisconsin Alumni Research Foundation and Princeton University. His research has not only advanced scientific understanding but has also paved the way for new treatment options in oncology.
Collaborations
Throughout his career, Yongna has collaborated with notable colleagues, including Yibin Kang and Liling Wan. These partnerships have contributed to the depth and impact of his research in the field.
Conclusion
Yongna Xing's innovative work in cancer treatment exemplifies the importance of research and development in medicine. His patents reflect a commitment to finding effective solutions for complex health challenges.